Company intelligence / Profile preview

Oceanblue

Miami, Florida, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Oceanblue produces commercial, over-the-counter omega-3 fish oil supplements intended for broad support of cardiovascular, brain, eye, joint, and immune health. All products are manufactured in GMP-certified US facilities, using highly purified fish oil distilled 27 times and tested for contaminants.

Therapeutic areas: ImmunologyRheumatologyOphthalmologyCardiovascularNeurology
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

4ocean (collaboration for ocean plastic neutral certification)

Beyond the preview

Go deeper on Oceanblue.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oceanblue.

Explore the full profile